A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers
Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers. European Journal Of Ophthalmology 2015, 26: 30-35. PMID: 26350994, DOI: 10.5301/ejo.5000673.Peer-Reviewed Original ResearchConceptsPositive Epstein-Barr virusEpstein-Barr virusTherapeutic trialsEBV infection/reactivationInfection/reactivationMassachusetts Eye ResearchCauses of uveitisRetrospective chart reviewImmunoglobulin G titersSurgery institutionsValganciclovir therapyEBV reactivationImmunomodulatory therapyIntraocular inflammationChart reviewIgG titersPersistent inflammationEA antibodyEBV-EAG titersValganciclovirNegative studiesUveitisPatientsInflammation